KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for West Pharmaceutical Services (WST) over the last 17 years, with Q3 2025 value amounting to -$2.1 million.

  • West Pharmaceutical Services' Other Working Capital Changes fell 220000.0% to -$2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$41.3 million, marking a year-over-year decrease of 66481.48%. This contributed to the annual value of -$22.6 million for FY2024, which is 20610.33% down from last year.
  • According to the latest figures from Q3 2025, West Pharmaceutical Services' Other Working Capital Changes is -$2.1 million, which was down 220000.0% from $4.1 million recorded in Q2 2025.
  • In the past 5 years, West Pharmaceutical Services' Other Working Capital Changes ranged from a high of $94.9 million in Q1 2021 and a low of -$185.4 million during Q4 2022
  • Moreover, its 5-year median value for Other Working Capital Changes was $100000.0 (2024), whereas its average is -$2.5 million.
  • Within the past 5 years, the most significant YoY rise in West Pharmaceutical Services' Other Working Capital Changes was 28083.54% (2021), while the steepest drop was 338260.87% (2021).
  • Quarter analysis of 5 years shows West Pharmaceutical Services' Other Working Capital Changes stood at -$10.2 million in 2021, then plummeted by 1717.65% to -$185.4 million in 2022, then soared by 85.98% to -$26.0 million in 2023, then plummeted by 66.15% to -$43.2 million in 2024, then soared by 95.14% to -$2.1 million in 2025.
  • Its last three reported values are -$2.1 million in Q3 2025, $4.1 million for Q2 2025, and -$100000.0 during Q1 2025.